Company Pharmacolog i Uppsala AB (publ) Nasdaq Stockholm
Equities
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- | - |
|
Business Summary
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Drugs Quality Assurance Solutions
100.0
%
| 10 | 100.0 % | 10 | 100.0 % | -1.76% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Sweden
100.0
%
| 10 | 100.0 % | 10 | 100.0 % | -1.76% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Hans Erik Dahlin
FOU | Founder | 79 | 15/07/15 |
LiseLotte Söder
DFI | Director of Finance/CFO | 60 | 01/21/01 |
Chairman | 76 | 01/17/01 | |
Asal Attabipour
PRN | Corporate Officer/Principal | 41 | 01/22/01 |
Susanne Grimsby
LAW | General Counsel | 63 | 01/18/01 |
Torbjörn Norberg
PRN | Corporate Officer/Principal | 59 | 01/18/01 |
Åsa Stroofe
SAM | Sales & Marketing | 56 | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 76 | 01/17/01 | |
Hans Erik Dahlin
FOU | Founder | 79 | 15/07/15 |
Ragnar Linder
BRD | Director/Board Member | 71 | 01/19/01 |
Director/Board Member | 47 | 30/23/30 | |
Anders Hedlund
CEO | Chief Executive Officer | - | 30/23/30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 108,520,716 | 74,802,036 ( 68.93 %) | 0 | 68.93 % |
Company contact information
![address Pharmacolog i Uppsala AB (publ)](https://cdn.zonebourse.com/static/address/43510671.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-55.41% | 2.2B | |
+17.78% | 1.83B | |
-14.62% | 1.42B | |
+17.58% | 1.18B | |
-24.88% | 864M | |
+1.25% | 784M | |
-37.13% | 723M | |
-30.24% | 590M | |
+15.09% | 575M |
- Stock Market
- Equities
- PERP B Stock
- Stock
- Company Pharmacolog i Uppsala AB (publ)